Hi All,
I was hoping someone in Biotech ER/VC/IB could share a model they used to forecast the IS for a pre-revenue company. Preferably one where there is a revenue build with # of patients, prevalence, adoption curve etc. included. This would be a massive help. Thanks in advance.
| +439 | Don’t work at UBS - UBS Sucks | 40 | 10h |
| +327 | Article - UBS’ Investment Bank Keeps Losing Ground | 41 | 4d |
| +186 | Should My Intern Get a Return Offer? | 53 | 12h |
| +64 | When to Leave Office as Intern | 8 | 6d |
| +56 | F*ck it I'm Going to Med School | 19 | 1d |
| +40 | Living in greenwich as an analyst? | 8 | 9h |
| +39 | Would you rather be a Touse Squid or a Bouse Mogger in IB | 2 | 5d |
| +39 | Getting Laid in IB? | 20 | 4h |
| +32 | STEM student lost in London IB recruiting | 18 | 15h |
| +27 | NYC Associate Budget | 9 | 7h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
bump
Pull an equity research report and copy their build.
SGMO, QURE, ONCE, GBT all have similar builds to what you describe.
Dolor laboriosam perferendis sed ut. Ipsum atque rerum soluta et. Nihil cum at et nemo.
Ex quasi consequatur molestias at. Libero sit perspiciatis in quos voluptas excepturi. Eius unde dolores saepe praesentium repellat quos unde.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...